In recent years, the significance of statistics in pharmaceutical compliance and quality management has become increasingly prominent. GMP regulatory such as pharmacopoeia, FDA guidelines, and ICH guiding principles all explicitly emphasize the necessity of statistics applications. Meanwhile, statistical analysis has become a fundamental requirement for scientific based quality management. Several companies have been cited for deficiencies due to inadequate statistics applications in recent years.
In addition to meeting compliance requirements, the scientific statistics application can significantly assist companies in optimizing processes, reducing costs, and enhancing product quality and stability. However, effective implementation of statistical analysis necessitates four simultaneous core competencies: knowledge of statistics, process knowledge, regulatory understanding, and practical application experience. The perception that "statistics are useless" often stems from the lack of one or more of these competencies.
gempex has a solid basis in statistical theory and extensive experience in CMC applications throughout the entire drug lifecycle. We are able to provide support with statistical analysis tailored to business and regulatory needs, assisting companies in achieving data-driven decision-making and continuous improvement.
"Statistics + GMP" – combined expertise from one team
Our core statisticians have supported R&D, technology transfer, and commercialization projects for leading domestic pharmaceutical companies, with extensive experience in production quality statistics from multinational pharmaceutical corporations.
Systematic approach
A complete, compliant, and efficient statistical work framework has been established to help companies reduce the cost of trial and error and rapidly improve their capabilities for statistical application.
Full lifecycle support
Covering the entire life cycle from research and development to commercialization, we provide statistical solutions that support the process, are compliant, and are feasible for implementation.
Type 1: Long-term cooperation service
- Statistical report writing: including annual quality review, statistical stability analysis report, statistical utility analysis report, etc;
- Statistical support during the drug development stage: including scale-down model implementation, process characterization, and statistics application support based on QbD;
- Other CMC statistical analysis support;
- Statistical support on a case-by-case basis.
Type 2: Project-based service
- Support for correcting statistical-related deficiencies identified during GMP inspections;
- Specialized statistics training: From a basic to advanced level, covering compliance and application scenarios;
- Gap analysis;
- Support on a case-by-case basis:
◦ Deviation investigation
◦ Change evaluation
◦ Sample storage period evaluation
◦ Other studies